Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E3XG
|
||||
Former ID |
DIB003168
|
||||
Drug Name |
Zolasartan
|
||||
Synonyms |
GR-117289
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hypotension [ICD9: 458, 796.3; ICD10:I95] | Discontinued in Phase 2 | [544984] | ||
Company |
Glaxo Wellcome plc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H20BrClN6O3
|
||||
Canonical SMILES |
n1(c(c(nc1CCCC)Cl)C(=O)O)Cc1cc2c(c(oc2cc1)c1c(c2nnn[nH]<br />2)cccc1)Br
|
||||
CAS Number |
CAS 145781-32-4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Type-1 angiotensin II receptor | Target Info | Agonist | [531650] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Arf6 trafficking events | ||||
Arf6 signaling events | |||||
Angiopoietin receptor Tie2-mediated signaling | |||||
PathWhiz Pathway | Angiotensin Metabolism | ||||
Muscle/Heart Contraction | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.